KHC
24
13
EQIX
64
2
HOG
35
2
GT
62
6
HAS
33
3
WBA
48
4
BAC
53
3
APD
59
2
ORCL
65
-2
HSIC
56
5
URBN
56
14
ES
34
3
KLAC
47
4
FDX
43
3
CMA
61
5
DG
6
2
INTC
33
-2
GS
75
2
EMN
60
4
HRB
57
5
KHC
24
13
EQIX
64
2
HOG
35
2
GT
62
6
HAS
33
3
WBA
48
4
BAC
53
3
APD
59
2
ORCL
65
-2
HSIC
56
5
URBN
56
14
ES
34
3
KLAC
47
4
FDX
43
3
CMA
61
5
DG
6
2
INTC
33
-2
GS
75
2
EMN
60
4
HRB
57
5
Financhill
Back

Macrogenics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy
52

MGNX
Macrogenics

Last Price:
3.24
Seasonality Move:
16.69%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
1.46%
Buy
52
Macrogenics (MGNX) is a Buy

Is Macrogenics a Buy, Sell or Hold?

  • The current Macrogenics [MGNX] share price is $3.24. The Score for MGNX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • MGNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MGNX Stock Price Chart

What is Macrogenics's stock price today?

  • The Macrogenics share price today is $3.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

MGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 37.78 Sell
Chaikin Money Flow: 57886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.39 - 4.09) Sell
Bollinger Bands (100): (3.21 - 4.47) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

MGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.48 Sell
20-day SMA: 3.73 Sell
50-day SMA: 3.63 Sell
200-day SMA: 8.02 Sell
8-day EMA: 3.47 Sell
20-day EMA: 3.65 Sell
50-day EMA: 3.75 Sell
200-day EMA: 5.92 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Macrogenics Earnings Growth & MGNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.80 per share, and a decrease next year of $1.14 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Macrogenics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):